| Old Articles: <Older 1141-1150 Newer> |
|---|
 |
The Motley Fool
April 27, 2004
Charly Travers |
More Biotech IPOs Can small biotech take on big pharma? You bet. A new biotech company decides to use its technology to battle large pharma head on. If all goes well, this could be one of the biggest drug development stories of the year.   |
The Motley Fool
April 26, 2004
J. Graham |
Sanofi Finally Nabs Aventis The French drug companies make a deal to merge. |
The Motley Fool
April 26, 2004
Alyce Lomax |
Genentech's Lucky Day Genentech and OSI Pharmaceuticals jump in today's trading session after favorable trial results for a cancer drug. |
The Motley Fool
April 26, 2004
Alyce Lomax |
Amerisource Hangs On While pharmaceutical distribution is an industry with obvious opportunities for financial reward, the potential for a price war remains a risk. |
The Motley Fool
April 23, 2004
Charly Travers |
A Difficult Drug Launch Investors expected a lot from Fuzeon, Trimeris' HIV drug therapy. However, anticipated sales for the biotechnology company didn't materialize. |
BusinessWeek
May 3, 2004
John Carey |
Is Reimporting Drugs A Cheap Fix? Not Really Why reimporting drugs from Canada won't work in the long run |
BusinessWeek
May 3, 2004
Dean Foust |
Weaker Vital Signs At Hospitals The number of patients in default on their bills is off the charts |
The Motley Fool
April 22, 2004
Brian Gorman |
Bausch & Lomb Delivers The 150-year-old eye-care company's sales aren't sizzling, but its profitability is improving. |
The Motley Fool
April 22, 2004
Rich Smith |
Kensey Nash Heals Fast Four months was all it took to rejuvinate biomedical products maker Kensey Nash's profit machine. |
The Motley Fool
April 21, 2004
Ben McClure |
Discount Pharmacy With prices beaten down across the pharmaceuticals industry and the quarterly reporting season here, do any investment opportunities pop up? |
| <Older 1141-1150 Newer> Return to current articles. |
